<DOC>
	<DOCNO>NCT00000439</DOCNO>
	<brief_summary>The purpose study test effectiveness sodium valproate ( Depacon ) treat individual alcohol dependence comorbid bipolar disorder .</brief_summary>
	<brief_title>Drug Treatment Alcoholics With Bipolar Disorder</brief_title>
	<detailed_description>The aim study test mood stabilizer , anticonvulsant , sodium valproate individual alcohol dependence bipolar disorder , double-blind , placebo-controlled , randomized trial 6 month duration . All subject treat treatment usual , include lithium carbonate individual dual recovery counsel randomize either sodium valproate placebo .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Meets criteria alcohol dependence comorbid bipolar disorder . Agreement participate outpatient treatment . Ability tolerate lithium carbonate randomize receive sodium valproate placebo . Stable living situation . Ability provide inform consent . Psychiatric condition include schizophrenia , schizoaffective disorder , nonbipolar psychotic disorder , unipolar major depression , mental retardation , sign impair cognitive functioning . Neurological condition include epilepsy , history brain injury , encephalitis , organic brain syndrome focally abnormal electroencephalographic examination . Medical condition include severe cardiac , liver , kidney , endocrine , hematologic , impair unstable medical condition impend surgery . Persistent elevation liver function enzymes indicate active liver disease . Pregnancy use acceptable contraceptive method . Inability read understand study form ; agree informed consent . Impending incarceration mandate attend treatment legal system alcohol use disorder . The presence either/or cocaine dependence , opioid dependence , intravenous drug use .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>